(Q48865711)

16 February 2018

title

Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. (English)

1 reference

16 February 2018

2

Kipnis J

1 reference

16 February 2018

Schwartz M

1

1 reference

16 February 2018

publication date

1 June 2001

1 reference

16 February 2018

Trends in Molecular Medicine

published in

1 reference

16 February 2018

volume

7

1 reference

16 February 2018

issue

6

1 reference

16 February 2018

page(s)

252-258

1 reference

16 February 2018

Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Potential neuroprotective therapy for glaucomatous optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Neuroprotection: a new treatment modality for glaucoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells In vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Unraveling immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Autoimmune T cells retard the loss of function in injured rat optic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Autoimmune T cells as potential neuroprotective therapy for spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Diffusion anisotropy MRI for quantitative assessment of recovery in injured rat spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7--2 (CD86) and prevention of cyst formation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Regulatory T cells in autoimmmunity*.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

The cognitive principle challenges clonal selection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Intrathymic expression of genes involved in organ specific autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

The major myelin protein genes are expressed in the human thymus.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

The third function of the thymus.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

V(beta)8(+) T cells protect from demyelinating disease in a viral model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

The role of protective CD8+ T cells in resistance of BALB/c mice to Theiler's murine encephalomyelitis virus-induced demyelinating disease: regulatory vs. lytic

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901993-1

7 January 2021

10.1016/S1471-4914(01)01993-1

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

11378514

1 reference

16 February 2018